Groundbreaking Alzheimer’s drug being dropped by manufacturer

The drug Aduhelm has a complicated history. It was greeted with great hope as a treatment for early stage Alzheimer’s disease. In 2021, the FDA gave it fast-track approval, that means a greenlight. It was the first new drug for Alzheimer’s in 18 years. Now, it’s being dropped by the manufacturer.